How Epstein–Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons

References

[1] O. G. Thomas, U. Rykaczewska, M. Galešić, et al., “Anoctamin-2-Specific T Cells Link Epstein–Barr Virus to Multiple Sclerosis,” Cell 189, no. 2 (2026): 585–602.

[2] J. Wang, Y. Qiu, Z. Marti, et al., “EBV Infection and HLA-DR15 Jointly Drive Multiple Sclerosis by Myelin Peptide Presentation,” Cell 189, no. 2 (2026): 569–584.

[3] H. Kim, M. Schneider, Y. Raach, et al., “Myelin Antigen Capture in the CNS by B Cells Expressing EBV Latent Membrane Protein 1 Leads to Demyelinating Lesion Formation,” Cell 189, no. 2 (2026): 603–619.

[4] J. Wang, I. Jelcic, L. Mühlenbruch, et al., “HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis,” Cell 183, no. 5 (2020): 1264–1281.

[5] M. Rojas, P. Restrepo-Jiménez, D. M. Monsalve, et al., “Molecular Mimicry and Autoimmunity,” Journal of Autoimmunity 95, no. 8 (2018): 100–123.

Rights & permissions

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.